Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
300 participants
INTERVENTIONAL
2023-03-15
2024-10-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Versus Late Enteral Iron in Infants Less Than 1301 Grams
NCT00458068
to Assess the Effect of Early vs Routine Iron Supplementation on Iron Store and Growth in Term Infants
NCT03171324
Brain and Behavior Depending on Timing of Iron Deficiency in Human Infants
NCT00642863
Timing of Iron Supplementation in Very Low Birth Weight Infants
NCT00683527
Prophylactic Iron and Nutrition in Preventing Infant Iron Deficiency
NCT06283342
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 daily iron supplementation
12.5 mg daily iron syrup supplementation from 6-9 months old, followed by 12.5 mg weekly iron syrup supplementation from 9-12 months old.
Infants aged 6-9 months will receive two iron syrup bottles. One bottle aims for ingestion every Monday of the week, and one bottle aims for ingestion on other days of the week.
At ages 9-12 months, infants will receive an iron syrup bottle that aims for ingestion every Monday of the week.
Iron supplement
Group 1: 12.5 mg daily iron syrup supplementation from 6-9 months old
Group 2 weekly iron supplementation
12.5 mg weekly iron syrup supplementation from 6-12 months old. Infants aged 6-9 months will receive an iron syrup bottle that aims for ingestion every Monday of the week and a placebo bottle that aims for ingestion on other days of the week.
At ages 9-12 months, infants will receive an iron syrup bottle that aims for ingestion every Monday of the week.
Iron supplement
Group 1: 12.5 mg daily iron syrup supplementation from 6-9 months old
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Iron supplement
Group 1: 12.5 mg daily iron syrup supplementation from 6-9 months old
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having a birth weight between 2,500 and 4,000 grams
* Being born full term (37 to 41 weeks of age + 6 days)
* Having hemoglobin ≥ 10.5 g/dL
* Being planned to breastfeed with complementary food and/or complementary foods with formula milk
Exclusion Criteria
* Previously or currently taking an iron supplement
6 Months
12 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Suranaree University of Technology
OTHER
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tippawan Pongcharoen, PhD
Role: PRINCIPAL_INVESTIGATOR
Mahidol University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samphran District Hospital
Sam Phran, Changwat Nakhon Pathom, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Tinnakorn Chuenchom, MD
Role: primary
Somchai Janelapwattanakul, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MU-CIRB 2022/313.1411
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.